{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:25:51Z","timestamp":1791663951211,"version":"4.3.4"},"reference-count":17,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":141,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004914","name":"Ferring Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004914","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019551","name":"Seres Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019551","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.gastha.2026.101025","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:51:15Z","timestamp":1779839475000},"page":"101025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Practice Variations in the Management of Clostridioides difficile Infection: Findings From a Survey of US Physicians"],"prefix":"10.1016","volume":"5","author":[{"given":"Abhishek","family":"Deshpande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L.","family":"Hohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Tomeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R.","family":"Allegretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastha.2026.101025_bib1","series-title":"AR antibiotic resistance threats in the United States, 2019","year":"2019"},{"key":"10.1016\/j.gastha.2026.101025_bib2","series-title":"Statpearls [internet]","article-title":"Clostridioides difficile","author":"Mada","year":"2022"},{"issue":"18","key":"10.1016\/j.gastha.2026.101025_bib3","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","article-title":"Changes in prevalence of health care-associated infections in U.S. hospitals","volume":"379","author":"Magill","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.gastha.2026.101025_bib4","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.14309\/ajg.0000000000001278","article-title":"ACG clinical guidelines: prevention, diagnosis, and treatment of Clostridioides difficile infections","volume":"116","author":"Kelly","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.gastha.2026.101025_bib5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/ciab718","article-title":"Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults","volume":"73","author":"Johnson","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.gastha.2026.101025_bib6","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/cid\/ciy149","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.gastha.2026.101025_bib7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/infdis\/jiae575","article-title":"Correspondence to \u201cescape velocity-the launch of microbiome therapies\u201d","volume":"231","author":"Olle","year":"2025","journal-title":"J Infect Dis"},{"issue":"15","key":"10.1016\/j.gastha.2026.101025_bib8","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s40265-022-01797-x","article-title":"Efficacy and safety of RBX2660 in PUNCH CD3, a phase III, randomized, double-blind, placebo-controlled trial with a bayesian primary analysis for the prevention of recurrent Clostridioides difficile infection","volume":"82","author":"Khanna","year":"2022","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.gastha.2026.101025_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa2106516","article-title":"SER-109, an oral microbiome therapy for recurrent Clostridioides difficile infection","volume":"386","author":"Feuerstadt","year":"2022","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.gastha.2026.101025_bib10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1053\/j.gastro.2024.09.030","article-title":"Safety and tolerability of CP101, a full-spectrum, oral microbiome therapeutic for the prevention of recurrent Clostridioides difficile infection: a phase 2 randomized controlled trial","volume":"168","author":"Allegretti","year":"2025","journal-title":"Gastroenterology"},{"issue":"16","key":"10.1016\/j.gastha.2026.101025_bib11","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1001\/jama.2023.4314","article-title":"VE303, a defined bacterial consortium, for prevention of recurrent Clostridioides difficile infection: a randomized clinical trial","volume":"329","author":"Louie","year":"2023","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.gastha.2026.101025_bib13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s40121-021-00417-7","article-title":"Clostridium difficile: diagnosis and the consequence of over diagnosis","volume":"10","author":"Lee","year":"2021","journal-title":"Infect Dis Ther"},{"issue":"6","key":"10.1016\/j.gastha.2026.101025_bib14","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/cid\/ciad792","article-title":"A randomized, double-blind, phase 3 safety and efficacy study of ridinilazole versus vancomycin for treatment of Clostridioides difficile infection: clinical outcomes with microbiome and metabolome correlates of response","volume":"78","author":"Okhuysen","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.gastha.2026.101025_bib15","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/cid\/ciac096","article-title":"Efficacy, safety, pharmacokinetics, and microbiome changes of ibezapolstat in adults with Clostridioides difficile infection: a phase 2a multicenter clinical trial","volume":"75","author":"Garey","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gastha.2026.101025_bib16","article-title":"Transitions of care in Clostridioides difficile infection: a need of the hour","volume":"15","author":"Khanna","year":"2022","journal-title":"Therap Adv Gastroenterol"},{"issue":"3","key":"10.1016\/j.gastha.2026.101025_bib18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/j.gastro.2024.01.008","article-title":"AGA clinical practice guideline on fecal microbiota-based therapies for select gastrointestinal diseases","volume":"166","author":"Peery","year":"2024","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gastha.2026.101025_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1053\/j.gastro.2020.09.038","article-title":"Fecal microbiota transplantation is highly effective in real-world practice: initial results from the FMT national registry","volume":"160","author":"Kelly","year":"2021","journal-title":"Gastroenterology"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326001469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326001469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:14:36Z","timestamp":1789031676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572326001469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2772572326001469"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2026.101025","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Practice Variations in the Management of Clostridioides difficile Infection: Findings From a Survey of US Physicians","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2026.101025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"101025"}}